Home/AngioInsight/Gabrielle Zaeska
GZ

Gabrielle Zaeska

SVP, Regulatory Affairs and Quality

AngioInsight

Therapeutic Areas

AngioInsight Pipeline

DrugIndicationPhase
AngioAI+™ PlatformDiagnosis and management of Coronary Artery Disease (CAD) and Coronary Microvascular Disease (CMD)Investigational